VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,691,824
- Total 13F shares
- 237,170,581
- Share change
- +2,513,596
- Total reported value
- $68,704,605,708
- Put/Call ratio
- 84%
- Price per share
- $289.54
- Number of holders
- 1,108
- Value change
- +$746,235,756
- Number of buys
- 532
- Number of sells
- 483
Quarterly Holders Quick Answers
What is CUSIP 92532F100?
CUSIP 92532F100 identifies VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92532F100:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
9.9%
|
25,137,152
|
$7,083,398,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.2%
|
20,838,475
|
$5,872,075,000 | — | 30 Jun 2022 | |
| FMR LLC |
13F
|
Company |
6.6%
|
16,753,011
|
$4,720,832,000 | — | 30 Jun 2022 | |
| Capital World Investors |
13F
|
Company |
4.9%
|
12,569,932
|
$3,542,061,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
4.8%
|
12,264,049
|
$3,455,886,000 | — | 30 Jun 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
3.7%
|
9,300,230
|
$2,620,712,000 | — | 30 Jun 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.2%
|
8,235,639
|
$2,320,720,000 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.1%
|
5,237,542
|
$1,475,887,000 | — | 30 Jun 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.9%
|
4,962,683
|
$1,398,434,000 | — | 30 Jun 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.8%
|
4,562,949
|
$1,285,499,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
4,534,484
|
$1,275,406,000 | — | 30 Jun 2022 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.8%
|
4,457,736
|
$1,256,145,000 | — | 30 Jun 2022 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.7%
|
4,342,112
|
$1,223,563,000 | — | 30 Jun 2022 | |
| Clearbridge Investments, LLC |
13F
|
Company |
1.7%
|
4,243,264
|
$1,195,709,000 | — | 30 Jun 2022 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.2%
|
3,122,314
|
$879,836,863 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
2,936,934
|
$827,598,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
2,696,798
|
$759,932,000 | — | 30 Jun 2022 | |
| NORGES BANK |
13F
|
Company |
0.87%
|
2,226,598
|
$627,433,050 | — | 30 Jun 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0.86%
|
2,200,749
|
$620,151,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.82%
|
2,098,300
|
$591,280,000 | — | 30 Jun 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.8%
|
2,041,172
|
$575,181,000 | — | 30 Jun 2022 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.74%
|
1,877,088
|
$528,945,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.72%
|
1,827,225
|
$514,894,000 | — | 30 Jun 2022 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.7%
|
1,772,568
|
$499,492,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.69%
|
1,761,168
|
$496,280,000 | — | 30 Jun 2022 | |
| HARDING LOEVNER LP |
13F
|
Company |
0.68%
|
1,733,691
|
$488,540,000 | — | 30 Jun 2022 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.65%
|
1,648,974
|
$464,664,000 | — | 30 Jun 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.64%
|
1,638,952
|
$461,857,000 | — | 30 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.54%
|
1,364,092
|
$384,387,000 | — | 30 Jun 2022 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Company |
0.5%
|
1,279,094
|
$360,436,000 | — | 30 Jun 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.49%
|
1,251,904
|
$352,773,000 | — | 30 Jun 2022 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.47%
|
1,201,904
|
$338,684,000 | — | 30 Jun 2022 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.46%
|
1,179,534
|
$332,381,000 | — | 30 Jun 2022 | |
| Bellevue Group AG |
13F
|
Company |
0.46%
|
1,176,136
|
$331,423,000 | — | 30 Jun 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.44%
|
1,122,794
|
$316,393,000 | — | 30 Jun 2022 | |
| Swiss National Bank |
13F
|
Company |
0.43%
|
1,104,275
|
$311,174,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.41%
|
1,047,640
|
$295,214,000 | — | 30 Jun 2022 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.4%
|
1,029,432
|
$290,084,000 | — | 30 Jun 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.39%
|
990,959
|
$279,240,000 | — | 30 Jun 2022 | |
| Amundi |
13F
|
Individual |
0.37%
|
931,387
|
$266,517,000 | — | 30 Jun 2022 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.37%
|
933,179
|
$262,961,000 | — | 30 Jun 2022 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.36%
|
928,307
|
$261,588,000 | — | 30 Jun 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.35%
|
885,235
|
$249,451,000 | — | 30 Jun 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.35%
|
881,645
|
$248,425,000 | — | 30 Jun 2022 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.34%
|
863,906
|
$243,438,000 | — | 30 Jun 2022 | |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. |
13F
|
Company |
0.34%
|
861,593
|
$242,789,000 | — | 30 Jun 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.31%
|
799,702
|
$225,348,000 | — | 30 Jun 2022 | |
| Avidity Partners Management LP |
13F
|
Company |
0.31%
|
793,000
|
$223,459,000 | — | 30 Jun 2022 | |
| APG Asset Management N.V. |
13F
|
Company |
0.32%
|
820,355
|
$221,118,000 | — | 30 Jun 2022 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.29%
|
749,795
|
$211,043,216 | — | 30 Jun 2022 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q3 2022
As of 30 Sep 2022,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
1,108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
237,170,581 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, FMR LLC, Capital World Investors, STATE STREET CORP, ALLIANCEBERNSTEIN L.P., WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, and JPMORGAN CHASE & CO.
This page lists
1,109
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
1,093
Q3 2022 holders
1,108
Holder diff
15
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.